Antineoplastiske midler, og især alkylerende midler, har været forbundet med en mulig risiko for myelodysplastisk syndrom (MDS) og sekundære maligne lidelser, inklusive leukæmi. ###>Antineoplastic agents, and notably alkylating agents, have been associated with a potential risk of myelodysplastic syndrome (MDS) and secondary malignancies, including leukaemia.